Skip to main content

Table 4 Relationships between ECG abnormalities and chemotherapy regimens

From: The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study

Chemotherapy regimen

Total (cases)

ST-T segment abnormalities

Elevated myocardial enzymes

Arrhythmia

QRS pattern or duration abnormalities

No. of events [cases (%)]

χ2

P value

No. of events [cases (%)]

χ2

P value

No. of events [cases (%)]

χ2

P value

No. of events [cases (%)]

χ2

P value

Anthracycline-based

22

12 (54.5)

6.977

0.008

0 (0)

0.020

0.889

4 (18.2)

2.519

0.112

4 (18.2)

1.224

0.269

Taxane-based

56

13 (23.2)

2.331

0.127

1 (1.8)

0.001

0.980

21 (37.5)

0.179

0.672

2 (3.6)

2.687

0.001

Anthracycline–taxane-based

66

19 (28.8)

0.188

0.665

3 (4.5)

0.515

0.430

25 (37.9)

0.329

0.566

8 (12.1)

0.938

0.333

Others

3

1 (33.3)

0.000

1.000

0

0.000

1.000

2 (66.7)

0.287

0.592

0

0.000

1.000